Kalaris Therapeutics(Klrs) Financials: Total Asset Turnover Compared To Industry Average, Plus Other Key Ratios
Growth Trend (Last 5 Years)
Growth - total asset turnover
This chart shows the historical trend of total asset turnover for KLRS compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Total Asset Turnover
Definition: Total asset turnover measures how efficiently the company generates sales from its entire asset base. A high turnover means the company gets a lot of sales out of relatively fewer assets — very efficient. A low turnover may suggest underused assets or bloated balance sheets.
Interpretation:
• In '2022', KLRS's total asset turnover was 0.00, reflecting overall efficiency in utilizing assets. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2022' stood at 0.13.
• In '2023', KLRS's total asset turnover was 0.00, reflecting overall efficiency in utilizing assets. The figure remained stable compared to '2022'. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2023' stood at 0.13. Industry average declined by 0.00 from previous year.
Overall, KLRS's total asset turnover has remained generally stable over the past 2 years.
Formula: Total Asset Turnover = Net Sales / Total Assets
Good Range: Ranges from 0.5 to 2 depending on business type.